| Averi Strickland, | |
|
1724 N Burnside Ave Ste 7, Gonzales, LA 70737-2157 | |
| (225) 644-8565 | |
| Not Available |
| Full Name | Averi Strickland |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 1724 N Burnside Ave Ste 7, Gonzales, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407394414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Averi Strickland, 1724 N Burnside Ave Ste 7, Gonzales, LA 70737-2157 Ph: (225) 644-8565 | Averi Strickland, 1724 N Burnside Ave Ste 7, Gonzales, LA 70737-2157 Ph: (225) 644-8565 |
News Archive
A new study of twins finds that genetics play a significant role in how affectionate women are, but the same can't be said for men.
QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.
Researchers studying stroke patients have found a strong association between impairments in a network of the brain involved in emotional regulation and the severity of post-stroke depression. Results of the study are published online in the journal Radiology.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has completed its targeted enrollment of Phase III clinical trials for CM-AT, its autism treatment.
Santarus, Inc. today announced that it has begun patient enrollment in a multicenter, randomized, double-blind, placebo-controlled Phase IIIb clinical study with the investigational drug UCERIS (budesonide) tablets 9 mg to evaluate whether there is an incremental benefit when UCERIS 9 mg is added to current oral aminosalicylate (5-ASA) therapy for patients with mild or moderate active ulcerative colitis who are not adequately controlled on background 5-ASA therapy.
› Verified 5 days ago
Stacey G Moreau, M.ED., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1112 E Ascension Complex Blvd, Gonzales, LA 70737 Phone: 225-621-5775 Fax: 225-644-2846 | |
Mrs. Laurice Derozan Harrison, DR. Counselor Medicare: Not Enrolled in Medicare Practice Location: 214 S. Burnside Ave, Ste 203, Gonzales, LA 70737 Phone: 225-647-9001 Fax: 225-647-9001 | |
Lance Joseph Miguez, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12320 Highway 44 Ste 3d, Gonzales, LA 70737 Phone: 225-253-3357 | |
Alexis Ray Russell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14430 Caribbean Dr, Gonzales, LA 70737 Phone: 225-993-6861 | |
Candace Sharper, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1058 E Worthy St, Gonzales, LA 70737 Phone: 225-258-7322 Fax: 225-450-3799 | |
Lisa Schuster, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1112 E Ascension Complex Blvd, Gonzales, LA 70737 Phone: 225-450-1016 | |
Mrs. Alexis Cecilia Washington, M.ED. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1724 N Burnside Ave, Gonzales, LA 70737 Phone: 225-644-8565 |